CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings

Молимо вас користите овај идентификатор за цитирање или овај линк до ове ставке: https://scidar.kg.ac.rs/handle/123456789/15053

Назив:	CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings
Аутори:	Todorovic Z. Jakovcev-Todorovic D. Grbovic-Markovic V. Ladjevac N. Zdravković N. Djurdjevic, Predrag Arsenijevic, Nebojsa Milovanovic, Marija Arsenijevic A. Milovanovic, Jelena
Датум издавања:	2022
Сажетак:	Chimeric antigen receptor T (CAR T) cell therapy achieved remarkable success in B-cell leukemia and lymphoma which led to its incorporation in treatment protocols for these diseases. CAR T cell therapy for chronic lymphocytic leukemia (CLL) patients showed less success compared to other malignant tumors. In this review, we discuss the published results regarding CAR T cell therapy of CLL, possible mechanisms of failures and expected developments.
URI:	https://scidar.kg.ac.rs/handle/123456789/15053
Тип:	review
DOI:	10.3390/curroncol29050293
SCOPUS:	2-s2.0-85130550535
Налази се у колекцијама:	Faculty of Medical Sciences, Kragujevac